ShareValue scores for NSPR: Valuation 54, Quality 33, Growth 70, Health 60.

NSPR
NASDAQ

InspireMD Inc

$0.65(-3.25%)
Loading chart...
Sentiment

Verdicts

Rating

Trap Risk

Return

7% to 18%
Valuation
54
Fair Value
Price vs Value
Quality
33
Weak
Business Strength
Growth
70
Moderate
Revenue & Earnings
Health
60
Moderate
Financial Stability
Momentum
17
Bearish
Price Trend

Company Details

About

InspireMD, Inc., a medical device company, focuses on the development and commercialization of products for the treatment of carotid artery disease and other vascular conditions in the United States, Germany, Italy, Russia, Poland, and internationally. It offers MicroNet, a biocompatible polymer mesh material for medical implants, as well as for treating plaque prolapse and embolization; CGuard carotid embolic prevention system (EPS) for use in carotid artery applications; CGuard Prime Carotid Stent System; and SwitchGuard neuroprotection system to provide flow reversal of cerebral protection in carotid interventions, as well as treating acute stroke with tandem lesions. The company was founded in 2005 and is headquartered in Miami, Florida.

Score Analysis

AI Investment Thesis

Data as of:Aug 3, 2026
|
Last calculated:Aug 3, 2026